Search

Your search keyword '"Dusheiko, Geoff"' showing total 3 results
Start Over Author "Dusheiko, Geoff" Region africa south of the sahara
3 results on '"Dusheiko, Geoff"'

1. Prevalence of HIV/hepatitis B and HIV/hepatitis C coinfection among people of East, South, Central and West African ancestry in the United Kingdom.

Author

Hung R, Patel N, Fox J, Cosgrove C, Pett SL, Burns F, Ustianowski A, Rosenvinge M, Bhagani S, Dusheiko G, Childs K, and Post FA

Subjects
Africa South of the Sahara epidemiology, Hepatitis B virus, Humans, Prevalence, United Kingdom epidemiology, Coinfection epidemiology, HIV Infections complications, HIV Infections epidemiology, Hepatitis B complications, Hepatitis B epidemiology, Hepatitis C complications, Hepatitis C epidemiology
Abstract

Regional variability in the prevalence of hepatitis B (HBV) and C (HCV) is reported in sub-Saharan Africa, although data for people with HIV are sparse. We determined the prevalence of HBV/HCV in 2473 people of African ancestry with HIV in the UK. Overall, 6.2% were co-infected with HBV and 1.3% with HCV. Central [adjusted odds ratio (aOR) 2.40 (95% confidence interval (CI) 1.23--4.67) and West [2.10 (1.29-3.41)] African ancestry was associated with HBV and Central [6.98 (2.00-24.43)] African ancestry with HCV., (Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)

Published
2021
Full Text
View/download PDF

2. Risk stratification in chronic hepatitis B patients for hepatocellular carcinoma surveillance: management in migrant sub-Saharan African populations.

Author

Cargill Z, Brown SE, Dusheiko G, and Agarwal K

Subjects
Africa South of the Sahara epidemiology, Humans, Risk Assessment, Carcinoma, Hepatocellular diagnosis, Carcinoma, Hepatocellular epidemiology, Carcinoma, Hepatocellular therapy, Hepatitis B, Hepatitis B, Chronic complications, Hepatitis B, Chronic diagnosis, Hepatitis B, Chronic drug therapy, Liver Neoplasms diagnosis, Liver Neoplasms epidemiology, Liver Neoplasms therapy, Transients and Migrants
Abstract

Competing Interests: Competing interests: ZC, SB and GD have no conflicts of interest to declare; KA has grant funding from Abbott, Gilead and MSD. He provides consultancy/speaker bureau for Assembly, Aligos, Arbutus, Gilead, Immunocore, Janssen, Roche, Sobi, Shinoigi and Vir.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results